endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news
Sammy Farah, Turnstone Biologics CEO
July 28, 2022 09:50 AM EDTUpdated 03:20 PM
Pharma

Take­da ax­es clin­i­cal-stage pro­gram in $1B+ Turn­stone Bi­o­log­ics col­lab­o­ra­tion

Kyle LaHucik

Biotech Correspondent

Take­da has end­ed its work with Turn­stone Bi­o­log­ics on a sol­id tu­mor as­set that was in a Phase I/IIa study, up­end­ing a 2019 deal that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

A decade af­ter its ill-fat­ed $40.5B megadeal, Te­va piv­ots from gener­ics to in­no­va­tion

Trump's health ap­pointees pledge sup­port for cell and gene ther­a­pies at FDA round­table

Re­gen­eron plans to buy 23andMe for $256M

FDA's Makary looks at ways to speed drug ap­provals, talks about cut­ting user fees

sponsored

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

A service from the Financial Times